Continued Active R&D
First written in FY2017-Q1. 31 of 32 entries say "Restated". Latest entry: FY2026.
- FY2026RestatedAnnual report
「Total R&D expenditure by the Group for the current consolidated fiscal year, including the improvement and application of existing products, was ¥6.166 billion.」
The company continued its R&D activities and disclosed total R&D expenditure of ¥6.166 billion. - FY2026-H1RestatedAnnual report
「Group-wide R&D expenditure for the interim consolidated fiscal period was ¥2.965 billion. There were no material changes in the status of the Group's R&D activities during the interim consolidated fiscal period.」
The company continued its R&D activities and disclosed R&D expenditure of ¥2.965 billion for the interim consolidated fiscal period. It stated that there were no material changes in the status of those activities. - FY2025RestatedAnnual report
「Total R&D expenditure by the Group for the current consolidated fiscal year, including the improvement and application of existing products, was ¥5.939 billion. In the mobility business, the Group is developing electronically controlled fuel injection systems and thermal management systems that contribute to improved fuel economy and vehicle electrification, with the aim of reducing CO2 emissions.」
The company continued its R&D activities and recorded total R&D expenditure of ¥5.939 billion. It also reported development work related to vehicle electrification, thermal management, and battery and motor temperature management for battery electric vehicles. - FY2025-H1RestatedAnnual report
「Group-wide R&D expenditure for the interim consolidated fiscal period was ¥3.007 billion. There were no material changes in the status of the Group's R&D activities during the interim consolidated fiscal period.」
The company continued its R&D activities and disclosed R&D expenditure of ¥3.007 billion for the interim consolidated fiscal period. It stated that there were no material changes in the status of those activities. - FY2024-Q3RestatedAnnual report
「Group-wide R&D expenditure for the nine months ended the third quarter of the current consolidated fiscal year was ¥4.223 billion. There were no material changes in the status of the Group's R&D activities during the nine months ended the third quarter of the current consolidated fiscal year.」
The company continued its R&D activities and disclosed R&D expenditure of ¥4.223 billion for the nine months ended the third quarter of the current consolidated fiscal year. It stated that there were no material changes in the status of those activities. - FY2024-Q2RestatedAnnual report
「Group-wide R&D expenditure for the six months ended the second quarter of the current consolidated fiscal year was ¥2.899 billion. There were no material changes in the status of the Group's R&D activities during the six months ended the second quarter of the current consolidated fiscal year.」
The company continued its R&D activities and disclosed cumulative R&D expenditure of ¥2.899 billion. It stated that there were no material changes in the status of those activities. - FY2024-Q1RestatedAnnual report
「Group-wide R&D expenditure for the three months ended the first quarter of the current consolidated fiscal year was ¥1.389 billion. There were no material changes in the status of the Group's R&D activities during the three months ended the first quarter of the current consolidated fiscal year.」
The company continued its R&D activities and disclosed R&D expenditure of ¥1.389 billion for the three months ended the first quarter of the current consolidated fiscal year. It stated that there were no material changes in the status of those activities. - FY2023-Q3RestatedAnnual report
「Group-wide R&D expenditure for the nine months ended the third quarter of the current consolidated fiscal year was ¥4.05 billion. There were no material changes in the status of the Group's R&D activities during the nine months ended the third quarter of the current consolidated fiscal year.」
The company continued its R&D activities and disclosed R&D expenditure of ¥4.05 billion for the nine months ended the third quarter of the current consolidated fiscal year. It stated that there were no material changes in the status of those activities. - FY2023-Q2RestatedAnnual report
「Group-wide R&D expenditure for the six months ended the second quarter of the current consolidated fiscal year was ¥2.668 billion. There were no material changes in the status of the Group's R&D activities during the six months ended the second quarter of the current consolidated fiscal year.」
The company continued its R&D activities and disclosed R&D expenditure of ¥2.668 billion for the six months ended the second quarter of the current consolidated fiscal year. It stated that there were no material changes in the status of those activities. - FY2023-Q1RestatedAnnual report
「Group-wide R&D expenditure for the three months ended the first quarter of the current consolidated fiscal year was ¥1.306 billion. There were no material changes in the status of the Group's R&D activities during the three months ended the first quarter of the current consolidated fiscal year.」
The company continued its R&D activities and disclosed R&D expenditure of ¥1.306 billion for the three months ended the first quarter of the current consolidated fiscal year. It stated that there were no material changes in the status of those activities. - FY2022RestatedAnnual report
「Total R&D expenditure by the Group for the current consolidated fiscal year, including the improvement and application of existing products, was ¥5.368 billion.」
The company continued its R&D activities and disclosed total annual R&D expenditure of ¥5.368 billion. In automotive-related products, it is advancing the development of products that contribute to improved fuel economy and vehicle electrification, among other areas. - FY2022-Q3RestatedAnnual report
「Group-wide R&D expenditure for the nine months ended the third quarter of the current consolidated fiscal year was ¥3.968 billion. There were no material changes in the status of the Group's R&D activities during the nine months ended the third quarter of the current consolidated fiscal year.」
The company continued its R&D activities and disclosed R&D expenditure of ¥3.968 billion for the nine months ended the third quarter of the current consolidated fiscal year. It stated that there were no material changes in the status of those activities. - FY2022-Q2RestatedAnnual report
「Group-wide R&D expenditure for the six months ended the second quarter of the current consolidated fiscal year was ¥2.596 billion. There were no material changes in the status of the Group's R&D activities during the six months ended the second quarter of the current consolidated fiscal year.」
The company continued its R&D activities and disclosed R&D expenditure of ¥2.596 billion for the six months ended the second quarter of the current consolidated fiscal year. It stated that there were no material changes in the status of those activities. - FY2022-Q1RestatedAnnual report
「Group-wide R&D expenditure for the three months ended the first quarter of the current consolidated fiscal year was ¥1.256 billion. There were no material changes in the status of the Group's R&D activities during the three months ended the first quarter of the current consolidated fiscal year.」
The company continued its R&D activities and disclosed R&D expenditure of ¥1.256 billion for the three months ended the first quarter of the current consolidated fiscal year. It stated that there were no material changes in the status of those activities. - FY2021RestatedAnnual report
「Total R&D expenditure by the Group for the current consolidated fiscal year, including the improvement and application of existing products, was ¥5.081 billion.」
The company continued its R&D activities and recorded total annual R&D expenditure of ¥5.081 billion. In automotive-related products, it is advancing the development of thermal management systems, electric exhaust control valves, electric vacuum pumps and electric oil pumps, among other products. - FY2021-Q3RestatedAnnual report
「Group-wide R&D expenditure for the nine months ended the third quarter of the current consolidated fiscal year was ¥3.774 billion. There were no material changes in the status of the Group's R&D activities during the nine months ended the third quarter of the current consolidated fiscal year.」
The company continued its R&D activities and disclosed cumulative R&D expenditure of ¥3.774 billion. It stated that there were no material changes in the status of those activities. - FY2021-Q2RestatedAnnual report
「Group-wide R&D expenditure for the six months ended the second quarter of the current consolidated fiscal year was ¥2.503 billion. There were no material changes in the status of the Group's R&D activities during the six months ended the second quarter of the current consolidated fiscal year.」
The company continued its R&D activities and disclosed cumulative R&D expenditure of ¥2.503 billion. It stated that there were no material changes in the status of those activities. - FY2021-Q1RestatedAnnual report
「Group-wide R&D expenditure for the three months ended the first quarter of the current consolidated fiscal year was ¥1.281 billion. There were no material changes in the status of the Group's R&D activities during the three months ended the first quarter of the current consolidated fiscal year.」
The company continued its R&D activities and disclosed R&D expenditure of ¥1.281 billion for the three months ended the first quarter of the current consolidated fiscal year. It stated that there were no material changes in the status of those activities. - FY2020RestatedAnnual report
「Total R&D expenditure by the Group for the current consolidated fiscal year, including the improvement and application of existing products, was ¥5.935 billion. In automotive-related products, the Group is primarily conducting R&D on electronically controlled fuel injection systems and engine components, as well as on the underlying control, actuator, sensing and materials technologies.」
The company continued its R&D activities and disclosed total annual R&D expenditure of ¥5.935 billion. It is also advancing the development of thermal management systems, electric exhaust control valves, electric vacuum pumps and electric oil pumps, among other products. - FY2020-Q3RestatedAnnual report
「Group-wide R&D expenditure for the nine months ended the third quarter of the current consolidated fiscal year was ¥4.551 billion. There were no material changes in the status of the Group's R&D activities during the nine months ended the third quarter of the current consolidated fiscal year.」
The company continued its R&D activities and disclosed R&D expenditure of ¥4.551 billion for the nine months ended the third quarter of the current consolidated fiscal year. It stated that there were no material changes in the status of those activities. - FY2020-Q2RestatedAnnual report
「Group-wide R&D expenditure for the six months ended the second quarter of the current consolidated fiscal year was ¥3.09 billion. There were no material changes in the status of the Group's R&D activities during the six months ended the second quarter of the current consolidated fiscal year.」
The company continued its R&D activities and disclosed cumulative R&D expenditure of ¥3.09 billion. It stated that there were no material changes in the status of those activities. - FY2020-Q1RestatedAnnual report
「Group-wide R&D expenditure for the three months ended the first quarter of the current consolidated fiscal year was ¥1.521 billion. There were no material changes in the status of the Group's R&D activities during the three months ended the first quarter of the current consolidated fiscal year.」
The company continued its R&D activities and disclosed R&D expenditure of ¥1.521 billion for the three months ended the first quarter of the current consolidated fiscal year. It stated that there were no material changes in the status of those activities. - FY2019-Q3RestatedAnnual report
「Group-wide R&D expenditure for the nine months ended the third quarter of the current consolidated fiscal year was ¥4.503 billion. There were no material changes in the status of the Group's R&D activities during the nine months ended the third quarter of the current consolidated fiscal year.」
The company continued its R&D activities and disclosed R&D expenditure of ¥4.503 billion for the nine months ended the third quarter of the current consolidated fiscal year. It stated that there were no material changes in the status of those activities. - FY2019-Q2RestatedAnnual report
「Group-wide R&D expenditure for the six months ended the second quarter of the current consolidated fiscal year was ¥3.005 billion. There were no material changes in the status of the Group's R&D activities during the six months ended the second quarter of the current consolidated fiscal year.」
The company continued its R&D activities and disclosed cumulative R&D expenditure of ¥3.005 billion. It stated that there were no material changes in the status of those activities. - FY2019-Q1RestatedAnnual report
「Group-wide R&D expenditure for the three months ended the first quarter of the current consolidated fiscal year was ¥1.435 billion. There were no material changes in the status of the Group's R&D activities during the three months ended the first quarter of the current consolidated fiscal year.」
The company continued its R&D activities and disclosed R&D expenditure of ¥1.435 billion for the three months ended the first quarter of the current consolidated fiscal year. It stated that there were no material changes in the status of those activities. - FY2018-Q3RestatedAnnual report
「Group-wide R&D expenditure for the nine months ended the third quarter of the current consolidated fiscal year was ¥3.829 billion. There were no material changes in the status of the Group's R&D activities during the nine months ended the third quarter of the current consolidated fiscal year.」
The company continued its R&D activities and disclosed cumulative R&D expenditure of ¥3.829 billion. It stated that there were no material changes in the status of those activities. - FY2018-Q2RestatedAnnual report
「Group-wide R&D expenditure for the six months ended the second quarter of the current consolidated fiscal year was ¥2.497 billion. There were no material changes in the status of the Group's R&D activities during the six months ended the second quarter of the current consolidated fiscal year.」
The company continued its R&D activities and disclosed cumulative R&D expenditure of ¥2.497 billion. It stated that there were no material changes in the status of those activities. - FY2018-Q1RestatedAnnual report
「Group-wide R&D expenditure for the three months ended the first quarter of the current consolidated fiscal year was ¥1.219 billion. There were no material changes in the status of the Group's R&D activities during the three months ended the first quarter of the current consolidated fiscal year.」
The company continued its R&D activities and disclosed R&D expenditure of ¥1.219 billion for the three months ended the first quarter of the current consolidated fiscal year. It stated that there were no material changes in the status of those activities. - FY2017RestatedAnnual report
「Total R&D expenditure by the Group for the current consolidated fiscal year, including the improvement and application of existing products, was ¥4.831 billion.」
The company continued its R&D activities and disclosed total annual R&D expenditure of ¥4.831 billion, including ¥4.465 billion for the automotive-related products business. - FY2017-Q3RestatedAnnual report
「Group-wide R&D expenditure for the nine months ended the third quarter of the current consolidated fiscal year was ¥3.579 billion. There were no material changes in the status of the Group's R&D activities during the nine months ended the third quarter of the current consolidated fiscal year.」
The company continued its R&D activities and disclosed cumulative R&D expenditure of ¥3.579 billion. It stated that there were no material changes in the status of those activities. - FY2017-Q2RestatedAnnual report
「Group-wide R&D expenditure for the six months ended the second quarter of the current consolidated fiscal year was ¥2.378 billion. There were no material changes in the status of the Group's R&D activities during the six months ended the second quarter of the current consolidated fiscal year.」
The company continued its R&D activities and disclosed cumulative R&D expenditure of ¥2.378 billion, while stating that there were no material changes in the status of those activities. - FY2017-Q1First statedAnnual report
「The company continued its active R&D efforts, and operating profit was ¥751 million, down 10.2% year on year.」
R&D expenditure for the first quarter of the current consolidated fiscal year is disclosed as ¥1.182 billion.